Drug Profile
GRT 9906
Alternative Names: GRT 9906 PR; GRT9906Latest Information Update: 31 Dec 2018
Price :
$50
*
At a glance
- Originator Grunenthal
- Class Analgesics
- Mechanism of Action Adrenergic uptake inhibitors; Opioid mu receptor agonists; Serotonin uptake inhibitors
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity Yes
Highest Development Phases
- Discontinued Fibromyalgia; Neuropathic pain
Most Recent Events
- 31 Dec 2018 Discontinued - Phase-II for Fibromyalgia in USA (PO)
- 20 Dec 2018 Discontinued - Phase-II for Neuropathic pain in Germany, United Kingdom, Denmark (PO)
- 31 Dec 2012 No development reported - Phase-II for Neuropathic pain in Denmark (PO)